Brought to you by 
Yamanouchi co-develops Searle compounds for Japanese market
13 Jul 1999
Executive Summary
Yamanouchi has agreed to develop and commercialize for the Japanese market any GD Searle (a division of Monsanto) compound that enters development through 2001, The agreement currently encompasses ten lead compounds.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- Co-Marketing
- Co-Promotion
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Yamanouchi co-develops Searle compounds for Japanese market
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice